EDGAR Filing Documents for 0001047469-15-002966

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-15-002966

Filing Date

2015-03-31

Accepted

2015-03-30 20:46:05

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2223738z10-k.htm	10-K	1562220
2	EX-4.4	a2223738zex-4_4.htm	EX-4.4	81991
3	EX-4.5	a2223738zex-4_5.htm	EX-4.5	20898
4	EX-10.4	a2223738zex-10_4.htm	EX-10.4	37058
5	EX-10.5	a2223738zex-10_5.htm	EX-10.5	34031
6	EX-10.6	a2223738zex-10_6.htm	EX-10.6	32534
7	EX-21.1	a2223738zex-21_1.htm	EX-21.1	5985
8	EX-23.1	a2223738zex-23_1.htm	EX-23.1	4897
9	EX-31.1	a2223738zex-31_1.htm	EX-31.1	7842
10	EX-31.2	a2223738zex-31_2.htm	EX-31.2	7912
11	EX-32.1	a2223738zex-32_1.htm	EX-32.1	5942
18	G546868.JPG	g546868.jpg	GRAPHIC	75570
19	G798645.JPG	g798645.jpg	GRAPHIC	41506
20	G605714.JPG	g605714.jpg	GRAPHIC	27722
21	G221529.JPG	g221529.jpg	GRAPHIC	68612
	Complete submission text file	0001047469-15-002966.txt		15333089

Data Files

Seq	Description	Document	Type	Size
12	EX-101.INS	eprs-20141231.xml	EX-101.INS	2493953
13	EX-101.SCH	eprs-20141231.xsd	EX-101.SCH	85849
14	EX-101.CAL	eprs-20141231_cal.xml	EX-101.CAL	89384
15	EX-101.LAB	eprs-20141231_lab.xml	EX-101.LAB	751929
16	EX-101.PRE	eprs-20141231_pre.xml	EX-101.PRE	625553
17	EX-101.DEF	eprs-20141231_def.xml	EX-101.DEF	389566

Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116

Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164

EPIRUS Biopharmaceuticals, Inc. (Filer) CIK: 0001135906 (see all company filings)